Olio Labs — Combinatorial Therapeutics for Hard-to-Treat
Screenshot of Olio Labs

Olio Labs

Olio Labs is a biotech company developing combinatorial therapeutics for hard-to-treat diseases, targeting multiple proteins to identify synergistic

Screenshot

What is Olio Labs?

Olio Labs is a biotechnology company developing therapeutics using a combinatorial approach. Details about specific products and services require direct inquiry.

Who created Olio Labs?

Olio Labs was founded by David Tingley, PhD (Co-Founder & CEO) and Tom Roseberry, PhD (Co-Founder & CTO). Calder Cui is also part of the team as a Software Engineer.

What is Olio Labs used for?

Olio Labs focuses on a combinatorial therapeutics approach, designed to:

  • Target multiple proteins at once
  • Identify synergistic therapeutic combinations — therapies that work well together
  • Concentrate on challenging diseases that are hard to treat
  • Aim for more effective treatments for patients

The approach handles complex biological data and accounts for the broader context of protein interactions, which may enable novel treatment options and fewer side effects.

Who is Olio Labs for?

The core technology is aimed at scientists, doctors, and other professionals working in therapeutics and biological research. Some listings associate Olio Labs with creative and marketing roles such as designers and strategists, but this appears inconsistent with the company’s stated focus on biological data and therapeutics.

Learn more

Visit oliolabs.co to learn more about Olio Labs’ work or explore potential collaboration with the team.

Related

Related AI Tools

Discover more tools in similar categories

New tools, in your inbox.

Weekly picks of the best AI tools we've researched and added — no spam, unsubscribe anytime.

Join 25,000+ AI enthusiasts. No spam, unsubscribe anytime.